2m 2m 2m 2m 2m 2m 2m
NovoCure NPV (NVCR)
NASDAQ
$16.94+$1.12 (+7.07%)
Price as of Jun 03, 2026 5:57 PM EDT- $1.9BMarket Cap
- -7.16%1-Year Change
- Medical DevicesIndustry
NovoCure NPV (NVCR)
$16.94+$1.12 (+7.07%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 655.4M +8.28% | 605.2M +18.82% | 509.3M -5.30% | 537.8M +0.53% | |
Cost of Revenue | 166.9M +21.65% | 137.2M +6.94% | 128.3M +11.68% | 114.9M -0.009% | |
Gross Profit | 488.5M +4.37% | 468.0M +22.83% | 381.1M -9.91% | 423.0M +0.67% | |
Sales and Marketing Expense | 240.1M +0.42% | 239.1M +5.40% | 226.8M +30.61% | 173.7M +26.70% | |
Research and Development Expense | -224.5M +7.11% | -209.6M -6.01% | -223.1M +8.24% | -206.1M +2.38% | |
Depreciation and Amortization Expense | 14.7M +30.40% | 11.2M +2.43% | 11.0M +3.25% | 10.6M +3.64% | |
Total Operating Expenses | 642.3M +0.59% | 638.5M +4.01% | 613.9M +19.79% | 512.5M +10.34% | |
Operating Profit | -153.8M -9.79% | -170.5M -26.78% | -232.9M +160.12% | -89.5M +101.93% | |
Interest Income | 39.8M -22.02% | 51.0M +10.78% | 46.0M +191.55% | 15.8M +1,339.38% | |
Interest Expense | -22.2M +90.49% | -11.7M +137.73% | -4.9M -39.53% | -8.1M -8.21% | |
Interest Income and Expense and Net | 17.6M -55.38% | 39.3M -4.37% | 41.1M +435.76% | 7.7M +199.16% | |
Total Nonoperating Income and Expense | 17.6M -55.38% | 39.3M -4.37% | 41.1M +435.76% | 7.7M -13.15% | |
Income before Taxes | -136.3M +3.88% | -131.2M -31.59% | -191.7M +134.27% | -81.8M +57.17% | |
Income Taxes | -23,000 -100.06% | 37.5M +144.82% | 15.3M +43.18% | 10.7M +70.30% | |
Extraordinary Items | 4.9M +318.55% | 1.2M +135.09% | 493,000 -48.38% | 955,000 +47.15% | |
Net Income | -136.2M -19.21% | -168.6M -18.55% | -207.0M +123.75% | -92.5M +58.58% | |
Net Income from Continuing Operations Applicable to Common | -136.3M +3.88% | -131.2M -31.59% | -191.7M +134.27% | -81.8M +57.17% | |
Basic EPS and Net Income | -1.22 -21.79% | -1.56 -20.00% | -1.95 +121.59% | -0.88 +57.14% | |
Diluted EPS and Net Income | -1.22 -21.79% | -1.56 -20.00% | -1.95 +121.59% | -0.88 +57.14% | |
Basic Weighted Average Shares | 111.5M +3.37% | 107.8M +1.36% | 106.4M +1.65% | 104.7M +1.19% | |
Diluted Weighted Average Shares | 111.5M +3.37% | 107.8M +1.36% | 106.4M +1.65% | 104.7M +1.19% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 93.5M -42.88% | 163.8M -32.00% | 240.8M +108.82% | 115.3M -44.77% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 93.5M -42.88% | 163.8M -32.00% | 240.8M +108.82% | 115.3M -44.77% | |
Total Current Assets | 646.7M -41.56% | 1.1B +6.98% | 1.0B -6.94% | 1.1B +3.54% | |
Accumulated Depreciation | 41.9M +29.59% | 32.3M +15.56% | 28.0M +18.47% | 23.6M +6.82% | |
Property and Plant and Equipment and Net | 77.6M -0.07% | 77.7M +50.86% | 51.5M +57.53% | 32.7M +44.00% | |
Total Long-Term Assets | 157.6M +17.43% | 134.2M +20.13% | 111.7M +39.44% | 80.1M +21.45% | |
Total Assets | 804.3M -35.18% | 1.2B +8.26% | 1.1B -3.82% | 1.2B +4.58% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 0 -100.00% | 558.2M N/A | 0 N/A | 0 N/A | |
Total Current Liabilities | 223.2M -70.49% | 756.4M +322.29% | 179.1M +12.81% | 158.8M +11.34% | |
Total Long-Term Debt | 195.0M +100.46% | 97.3M -82.89% | 568.8M +0.59% | 565.5M +0.59% | |
Total Long-Term Liabilities | 240.6M +93.70% | 124.2M -79.45% | 604.5M +2.17% | 591.7M +0.90% | |
Total Liabilities | 463.9M -47.32% | 880.6M +12.37% | 783.6M +4.42% | 750.5M +2.95% | |
Retained Earnings | -1.3B +11.80% | -1.2B +17.11% | -985.5M +26.60% | -778.5M +13.49% | |
Total Stockholders Equity | 340.5M -5.47% | 360.2M -0.64% | 362.5M -17.83% | 441.2M +7.47% | |
Total Shares Outstanding | 112.5M +3.66% | 108.5M +1.35% | 107.1M +1.93% | 105.0M +1.04% | |
Cash Flow | |||||
Cash from Operating Activities | -49.0M +85.94% | -26.4M -64.04% | -73.3M -338.20% | 30.8M -62.80% | |
Capital Expenditures | 26.6M -37.82% | 42.9M +58.18% | 27.1M +26.85% | 21.4M -11.63% | |
Cash from Investing Activities | 437.3M +411.80% | -140.2M -176.16% | 184.1M +231.57% | -140.0M -3.37% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -451.3M -599.74% | 90.3M +472.08% | 15.8M +1.91% | 15.5M -39.73% | |
Financials Ratio | |||||
Gross Margin | 74.54% -3.62% | 77.33% +3.37% | 74.81% -4.87% | 78.64% +0.15% | |
Operating Margin | -23.47% -16.69% | -28.17% -38.38% | -45.72% +174.68% | -16.64% +100.88% | |
Return on Assets | -13.32% -5.71% | -14.13% -20.23% | -17.71% +123.11% | -7.94% +49.08% | |
Return on Equity | -38.89% -16.67% | -46.67% -9.43% | -51.52% +137.11% | -21.73% +65.17% | |
Revenue Growth | 8.28% -56.00% | 18.82% +455.23% | -5.30% -1,109.39% | 0.53% -93.62% | |
Current Ratio | 2.90 +98.03% | 1.46 -74.67% | 5.78 -17.51% | 7.00 -7.01% | |
Cash Ratio | 0.42 +93.58% | 0.22 -83.90% | 1.34 +85.12% | 0.73 -50.40% | |
Debt-to-Equity Ratio | 0.57 -68.52% | 1.82 +15.97% | 1.57 +22.42% | 1.28 -6.41% | |
Debt-to-Assets Ratio | 0.24 -54.10% | 0.53 +6.45% | 0.50 +4.57% | 0.47 -3.81% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow